Artemis Medicare Services Limited has submitted a regulatory disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding its participation in an investor conference.
The company will participate in the EMKAY Confluence 2026 annual investor conference with the theme 'India: Full Throttle Ahead'. The event is scheduled for Thursday, August 13, 2026, in Mumbai. The mode of interaction will be physical attendance at the conference.
The disclosure notes that the schedule is subject to changes in case of exigencies on the part of analysts, investors, or the company. The filing was submitted for information and records purposes to both the National Stock Exchange of India Limited (where the company is listed with symbol ARTEMISMED) and BSE Limited.